TNNT2 and amyloidosis: The objective of this study is to investigate the potential of the cardiac biomarkers NT-proBNP and hs-cTnT in predicting diagnosis of ATTRv-CM in TTRv carriers and ATTRv amyloidosis patients without cardiomyopathy.